Sex-specific effects of gestational and lactational coexposure to lead and cadmium on hepatic phase I and phase II xenobiotic/steroid-metabolizing enzymes and antioxidant status

Journal of Biochemical and Molecular Toxicology

Volumn 23, Issue 6, 2009, Pages 419-431

  Pillai, Prakash ^a   Patel, Ritesh ^a   Pandya, Chirayu ^a   Gupta, Sarita ^a  

^a M S UNIVERSITY OF BARODA   (India)

Author keywords

Cadmium; Gestational and lactational exposure; Hepatic steroid metabolizing enzymes; Lead

Indexed keywords

ACETIC ACID; ALKALINE PHOSPHATASE; ANTIOXIDANT; CADMIUM ACETATE; CATALASE; CHOLESTEROL; CREATININE; DNA; ENZYME; GAMMA GLUTAMYLTRANSFERASE; GLUCURONOSYLTRANSFERASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; GLYCOGEN; HYDROXYSTEROID DEHYDROGENASE; LEAD ACETATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GESTATION PERIOD; LACTATION; LIPID PEROXIDATION; LIVER; MALE; NONHUMAN; OXIDATIVE STRESS; PERINATAL DRUG EXPOSURE; PERINATAL PERIOD; PREGNANCY; PRENATAL DRUG EXPOSURE; RAT; SEX DIFFERENCE;

ANIMALS; ANTIOXIDANTS; CADMIUM; FEMALE; FETUS; GLUCURONOSYLTRANSFERASE; GLUTATHIONE TRANSFERASE; GROWTH HORMONE; LACTATION; LEAD; LIPID PEROXIDATION; LIVER; MALE; NADPH-FERRIHEMOPROTEIN REDUCTASE; PREGNANCY; RATS; SEX FACTORS; STEROIDS; XENOBIOTICS;

RATTUS;

EID: 74749104742     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.20305     Document Type: Article

References (81)

1. Guillette LJ Jr,Gunderson Mark P. Alterations in development of reproductive and endocrine systems of wildlife populations exposed to endocrine-disrupting contaminants. Reproduction 2001;122:857-864.
2. Niwa T, Kaneko H, Naritomi Y, Togawe A, Shiraga T, Iwasaki K, Tozuka Z, Hata T. Species and sex differences of testosterone and nifedipine oxidation in liver microsomes of rat, dog, andmonkey. Xenobiotica 1995;25:1041-1049.
3. Wilson VS, McLachlan JB, Falls JG, LeBlanc GA. Alteration in sexually dimorphic testosterone biotransformation profiles as a biomarker of chemically induced androgen disruption in mice. Environ Health Perspect 1999;107:377-384.
4. Wilson VS, LeBlanc GA. Endosulfan elevates testosterone biotransformation and clearance in CD-1 mice. Toxicol Appl Pharmacol 1998;148:158-168.
5. Parks LG, LeBlanc GA. Involvement of multiple biotransformation processes in the metabolic elimination of testosterone by juvenile and adult fathead minnows (Pimephales promelas). GenCompEndocrinol 1998;112:69-79.
6. Wilson VS, LeBlanc GA. The contribution of hepatic inactivation of testosterone to the lowering of serum testosterone levels by ketoconazole. Toxicol Sci 2000;54:128-137.
7. Legraverend C, Agneta M, Wells T, Robinson I, Gustafsson JA. Hepatic steroid hydroxylating enzymes are controlled by the sexually dimorphic pattern of growth hormone secretion in normal and dwarf rats. FASEB J 1992;6:711-718.
8. Luo Z, Hines RN. Regulation of flavin-containing monooxygenase 1 expression by Ying Yang 1 and hepatic nuclear factors 1 and 4. Mol Pharmacol 2001;60:1421-1430.
9. Prough RA, Linder MW, Pinaire JA, Xiao GH, Falkner KC. Hormonal regulation of hepatic enzymes involved in foreign compoundmetabolism. FASEB J 1996;10:1369-1377.
10. Pillai A, Laxmipriya, Rawal A, Gupta S. Effect of low level exposure of lead and cadmium on hepatic estradiol metabolism in female rats. Indian J Exp Biol 2002;40:807-811.
11. Rushmore TH, Kong AN. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. Curr Drug Metab 2002;3:481-490.
12. Zhang H, Bai X, Zheng X. Distribution of lead in fetal rat tissue at different days of pregnancy. Wei Sheng Yan Jiu 1999;28: 88-90.
13. Dearth RK, Hiney JD, Srivastava V, Burdick SB, Bratton GR, Dees WL. Effects of lead (Pb) exposure during gestation and lactation on female pubertal development in the rat. Reprod Toxicol 2002;16:343-352.
14. Webster WS. Chronic cadmium exposure during pregnancy in the mouse: Influence of exposure levels on fetal and maternal uptake. J Toxicol Environ Health 1988;24:183-192.
15. Korpela H, Loueniva R, Yrjanheikki E, Kauppila A. Lead and cadmium concentrations in maternal and umbilical cord blood, amniotic fluid, placenta, and amniotic membranes. Am J Obstet Gynecol 1989;155:1086-1089.
16. Whelton BD, Toomey JM, Bhattacharyya MH. Cadmium-109 metabolism in mice. Diet versus maternal stores as a source of cadmium transfer to mouse fetuses and pups during gestation and lactation. J Toxicol Environ Health 1993;40:531-546.
17. Samarawickrama GP, Webb M. The acute toxicity and teratogenicity of cadmium in the pregnant rat. J Appl Toxicol 1981;1:264-269.
18. Pond WG, Walker EF Jr. Effect of dietary Ca and Cd level of pregnant rats on reproduction and on dam and progeny tissuemineral concentrations. Proc Soc Exp Biol Med 1975;148:665-668.
19. Prigge E. Inhalative cadmium effects in pregnant and fetal rats. Toxicology 1978;10:297-309.
20. Quig D. Cysteine metabolism and metal toxicity. Altern Med Rev 1998;3:262-270.
21. Pillai A, Gupta S. Effect of gestational and lactational exposure to lead and cadmium on reproductive performance and hepatic oestradiol metabolizing enzymes. Toxicol Lett 2005;155:179-186.
22. Nampoothiri LP, Gupta S. Biochemical effects of gestational coexposure to lead and cadmium on reproductive performance, placenta, and ovary. J BiochemMol Toxicol 2008;22(5):337-344.
23. Park BK, Kitteringham NR, Pirmohamed M, Tucker GT. Relevance of induction of human drug-metabolizing enzymes: Pharmacological and toxicological implications. Br J Clin Pharmacol 1996;41:477-491.
24. Manson MM, Ball HWL, Barrett MC. Mechanism of action of dietary chemoprotective agents in rat liver: Induction of phase I and II drug metabolizing enzymes and aflatoxin B1 metabolism. Carcinogenesis 1997;18:1729-1738.
25. Swegert CV, Dave KR, Katyare SS. Effect of aluminiuminduced Alzheimer like condition on oxidative energy metabolism in rat liver, brain and heart mitochondria. Mech Age Dev 1999;112:27-42.
26. Williams CH, Kamin H. Microsomal triphosphopyridine nucleotide-cytochrome c reductase of liver. J Biol Chem 1962;237:587-595.
27. Habig WG, Pabst MJ, Jakoby WB. Glutathione Stransferase. The first enzymic step in mercapturic acid formation. J Biol Chem 1974;249:7130-7139.
28. Orlowski M, MeisterA. Isolation of γ-glutamyl transpeptidase from hog kidney. J Biol Chem 1965;240:338-347.
29. Shivanandappa T, Venkatesh S. A colorimetric assay method for 3 beta-hydroxy-delta5-steroid dehydrogenase. Anal Biochem 1997;254:57-61.
30. Gorski JP, Kasper CB. Purification and properties of microsomal UDP glucuronosyl transferase from rat liver. J Biol Chem 1977;252:1336-1343.
31. Ohkawa H, Ohishi N, Yagi K. Assay of lipid peroxidation in animal tissue by thiobarbituric acid reaction. Anal Biochem 1979;95:351-358.
32. Beutlar E, Gelbart J. Plasma glutathione in health and in patients with malignant disease. J Lab Clin Med 1985;105:581-584.
33. Paglia DE,Valentine WN. Studies on the quantitative and qualitative characterization of glutathione peroxidase. J Lab Med 1987;70:158-165.
34. Smith IK, Vierheller TL, Thorne CA. Assay of glutathione reductase in crude tissue homogenates using 5,5′-dithiobis(2-nitrobenzoic acid). Anal Biochem 1988;175:408-413.
35. Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974;47:469-474.
36. Hugo EA. Catalase. In: Bergmeyer HU, Bergmeyer J, Grabt M, editors. Methods of Biochemical Analysis. New York: VCH Publishers; 1987. Vol 3, pp 277-282.
37. Seifter S, Dayton S, Novic B, Muntwyler E. The estimation of glycogen with the anthrone reagent. Arch Biochem 1950;25:191-200.
38. Leffler HH, McDougald CH. Estimation of cholesterol in serum by means of improved techniques. Am J Clin Pathol 1963;39:311-314.
39. Burton K. Determination of DNA concentration with diphenylamine. In: Rossma L,Moldave K, editors.Methods in Enzymology. New York: Academic Press; 1968. Vol XII, Part B, p 163.
40. Lowry OH, Rosebourgh NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-275.
41. Bonsnes RM, Taussky HH. Colorimetric determination of creatinine by Jaffe reaction. J BiolChem1945;158:581-591.
42. Bowers GN Jr, McComb RB. Measurement of total alkaline phosphatase activity in human serum. Clin Chem 1975;21:1988-1995.
43. Reitman S, Frankel S. Colorimetric method for determination of serum transaminase activity. Am J Clin Pathol 1957;28:56-58.
44. Nakahama T, Inouye Y, Fukuhara M. Comparative study on in vitro inhibitory effects of heavy metals on rabbit drug-metabolizing enzymes. J Health Sci 2001;47(1):14-20.
45. Veldhuis JD. Gender differences in secretory activity of the human somatotropic (growth hormone) axis. Eur J Endocrinol 1996;134:287-295.
46. CheungNW, Liddle C, Coverdale S, Lou JC, Boyages SC. Growth hormone treatment increases cytochrome P450-mediated antipyrine clearance in man. J Clin Endocrinol Metab 1996;81:1999-2001.
47. Webb M. Toxicological significance of metallothionein. Experientia Suppl 1987;52:109-134.
48. Bhattacharyya MH, Sellers DA, Peterson DP. Postlactational changes in cadmium retention in mice orally exposed to cadmium during pregnancy and lactation. Environ Res 1986;40:145-154.
49. Bhattacharyya MH, Whelton BD, Peterson DP. Gastrointestinal absorption of cadmium in mice during gestation and lactation; part I: Short-term exposure studies. Toxicol Appl Pharmacol 1981;61:335-342.
50. Bhattacharyya MH,Whelton BD, Peterson PD. Gastrointestinal absorption of cadmium in mice during gestation and lactation; part II: Continuous exposure studies. Toxicol Appl Pharmacol 1982;66:368-375.
51. Bhattacharyya MH, Wilson AK, Rajan SS, Jonah M. Biochemical pathways in cadmium toxicity. In: Zalups RK, Koropatnick J, editors. Molecular Biology and Toxicology of Metals. New York: Taylor & Francis; 2000. pp 34-74.
52. Floris B, Bomboi G, Sechi P, Pirino S,Marongiu ML. Cadmium chronic administration to lactating ewes: Reproductive performance, cadmium tissue accumulation and placental transfer. Ann Chim 2000;90:703-708.
53. Cook JA, Marconi EA, Di Luzio NR. Lead, cadmium, endotoxin interaction: Effect on mortality and hepatic function. Toxicol Appl Pharmacol 1974;28:292-302.
54. Gustafsson JA. 1983 Regulation of sexual dimorphism in rat liver. In: Short RV, Balaban E, editors. The Differences Between the Sexes. New York: Cambridge University Press; 1994. pp 231-241.
55. Alvares AP, Leigh S, Cohn J, Kappas A. Lead and methyl mercury; effects of acute exposure on cytochrome P-450 and the mixed function oxidase system in the liver. J Exp Med 1972;135:1406-1409.
56. Abbas AB. Effect of mercuric chloride onmicrosomal enzyme system in mouse liver. Pharmacology 1980;21:59-63.
57. Roomi MW, Columbano A, Ledda-Columbano GM, Sarma DSR. Lead nitrate induces certain biochemical properties characteristic of hepatocyte nodules. Carcinogenesis 1986;7:1643-1646.
58. Falke HE, Zwennis WCM. Toxicity of lead acetate to female rabbits after chronic subcutaneous administration; part 1: Biochemical and clinical effects. Arch Toxicol 1990;64:522-529.
59. Nehru B,Kaushals S. Effect of lead on hepatic microsomal enzyme activity. J Appl Toxicol 1992;12:401-405.
60. Chow CP, Cornish HH. Effects of lead on the induction of hepatic microsomal enzymes by phenobarbital and 3,4-benzpyrene. Toxicol Appl Pharmacol 1978;43(2):219-228.
61. Hadley WM, Miya TS, Bousquet WF. Cadmium inhibition of hepatic drug metabolism in the rat. Toxicol Appl Pharmacol 1974;28:284-291.
62. Yoshida T, Ito Y, Suzuki Y, UchiymaM. Inhibition of hepatic UDP-glucuronyltransferase activity by organophosphate insecticides and by carbon disulfide in mice. Bull Environ Contam Toxicol 1976;15:402-424.
63. Hayes JA, Snider GL, Palmer KC. The evolution of biochemical damage in the rat lung after cadmium exposure. Am Rev Respir Dis 1976;113:121-130.
64. Teare FW, Jasansky P, Renaud L, Read PR. Acute effect of cadmium on hepatic drug metabolizing enzymes in the rat. Toxicol Appl Pharmacol 1977;41:57-65.
65. Aitio A, Ahotupa M, Parkki M. Inhibition of drugmetabolizing enzymes by heavymetals in vitro. Biochem Biophys Res Commun 1978;83:850-856.
66. Means JR, Carson GP, Schnell RC. Studies on the mechanism of cadmium-induced inhibition of the hepatic microsomal monooxygenase of the male rat. Toxicol Appl Pharmacol 1979;48:293-304.
67. Colby HD, Zulkoski JS, Johnson PB, Pope MR, Miles PR. Sites of action of cadmium in vitro on hepatic, adrenal, and pulmonary microsomal monooxygenases in guinea pigs. Toxicol Appl Pharmacol 1984;73110-118.
68. Ding H-P, Liu Y-G. A comparative study of the effects of cadmium on microsomal mixed-function oxidase activities between kidney cortex and liver. J Huazhong Univ Sci Technol Med Sci 1992;12(2):85-89.
69. Zhou J, Zhang J, Xie W. Xenobiotic nuclear receptormediated regulation of UDP-glucuronosyltransferases. Curr Drug Metab 2005;6(4):289-298.
70. Scheri R, Beuthin FC, Louis-Ferdinand RT. Effect of lead acetate on the kinetics of γ-glutamyl transpeptidase activity from neonatal rat pup brain. Drug Chem Toxicol 1981;4(4):363-371.
71. Karmakar R, Banerjee A, Datta S, Chatterjee M. Influence of cadmium intoxication on hepatic lipid peroxidation, glutathione level, and glutathione-S-transferase and γ-glutamyl transpeptidase activities: Correlation with chromosome aberrations in bone marrow cells. J Environ Pathol Toxicol Oncol 1999;18(4):277-287.
72. Hamden K, Carreaua S, Markib FA, Masmoudic H, El Feki A. Positive effects of green tea on hepatic dysfunction, lipid peroxidation and antioxidant defence depletion induced by cadmium. Biol Res 2008;41:331-339.
73. +-ATPase and acetylcholine esterase) in various regions of rat brain. Neurochem Int 1993;23:451-458.
74. Stohs SJ, Bagchi D, Hassoun E, Bagchi M. Oxidative mechanisms in the toxicity of chromium and cadmium ions. J Environ Pathol Toxicol Oncol 2001;20:77-88.
75. Wang X, Yin X, Bai X. Combined effect of lead and cadmium on lipid peroxidation in renal tubular epithelial cells of rats.Wei Sheng Yan Jiu 2002;31:232-234.
76. Hussain T, Shukla GS, Chandra SV. Effects of cadmium on superoxide dismutase and lipid peroxidation in liver and kidney of growing rats: In vivo and in vitro studies. Pharmacol Toxicol 1987;60:355-359.
77. 2, superoxide dismutase and xanthine oxidase. Environ Mol Mutagen 1998;31:352-361.
78. Ikediobi CO, Badisa VL, Ayuk-Takem LT, Latinwo LM, West J. Response of antioxidant enzymes and redox metabolites to cadmium-induced oxidative stress in CRL-1439 normal rat liver cells. Int J Mol Med 2004;14:87-92.
79. Jolibios LS Jr, Burrow ME, Swan KF, George WJ, Anderson M, Henson MC. Effects of cadmium on cell viability, trophoblastic development, and expression of low density lipoprotein receptor transcripts in cultured human placental cells. Reprod Toxicol 1999;13:473-480.
80. Nation JR,Grover CA, BrattonGR, Salinas JA. Behavioral antagonism between lead and cadmium. Neurotoxicol Teratol 1990;12:99-104.
81. Zikic RV, Stajn AS, Ognjanovie BI, Saicic ZS, Kostic MM, Pavlovic SZ. The effect of cadmium and selenium on the antioxidant enzyme activities in rat heart. J Environ Pathol Toxicol Oncol 1998;17:259-264.